Sushant Kumar Shrivastava (Sushant K Shrivastava)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Venues

ACS chemical neuroscience

ACS omega

Journal of biomolecular structure & dynamics

Journal of computer-aided molecular design

Indian Institute of Technology BHU

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Indian Institute of Technology BHU

India

Professor :: Department of Pharmaceutical Engineering & Technology

Publications

Akash Verma, Digambar Kumar Waiker, Neha Singh, Anima Roy, Namrata Singh, Poorvi Saraf, Bhagwati Bhardwaj, Sairam Krishnamurthy, Surendra Kumar Trigun, Sushant Kumar Shrivastava
Design, Synthesis, and Biological Investigation of Quinazoline Derivatives as Multitargeting Therapeutics in Alzheimer's Disease Therapy. ACS chemical neuroscience 15 (4) (2024)
Abhinav Singh, Akash Verma, Bhagwati Bhardwaj, Poorvi Saraf, Hansal Kumar, Nishi Jain, Digambar Kumar Waiker, T A Gajendra, Sairam Krishnamurthy, Sushant Kumar Shrivastava
Structure-Guided Design, Synthesis, and Biological Evaluation of Peripheral Anionic Site Selective and Brain Permeable Novel Oxadiazole-Piperazine Conjugates against Alzheimer's Disease with Antioxidant Potential. ACS omega 9 (16) (2024)
Akash Verma, Digambar Kumar Waiker, Neha Singh, Anima Roy, Namrata Singh, Poorvi Saraf, Bhagwati Bhardwaj, Sairam Krishnamurthy, Surendra Kumar Trigun, Sushant Kumar Shrivastava
Design, Synthesis, and Biological Investigation of Quinazoline Derivatives as Multitargeting Therapeutics in Alzheimer's Disease Therapy. ACS chemical neuroscience 15 (4) (2024)
Akash Verma, Digambar Kumar Waiker, Neha Singh, Anima Roy, Namrata Singh, Poorvi Saraf, Bhagwati Bhardwaj, Sairam Krishnamurthy, Surendra Kumar Trigun, Sushant Kumar Shrivastava
Design, Synthesis, and Biological Investigation of Quinazoline Derivatives as Multitargeting Therapeutics in Alzheimer's Disease Therapy. ACS chemical neuroscience 15 (4) (2024)
Akash Verma, Digambar Kumar Waiker, Neha Singh, Anima Roy, Namrata Singh, Poorvi Saraf, Bhagwati Bhardwaj, Sairam Krishnamurthy, Surendra Kumar Trigun, Sushant Kumar Shrivastava
Design, Synthesis, and Biological Investigation of Quinazoline Derivatives as Multitargeting Therapeutics in Alzheimer's Disease Therapy. ACS chemical neuroscience (2024)
Abhinav Singh, Akash Verma, Bhagwati Bhardwaj, Poorvi Saraf, Hansal Kumar, Nishi Jain, Digambar Kumar Waiker, T A Gajendra, Sairam Krishnamurthy, Sushant Kumar Shrivastava
Structure-Guided Design, Synthesis, and Biological Evaluation of Peripheral Anionic Site Selective and Brain Permeable Novel Oxadiazole-Piperazine Conjugates against Alzheimer's Disease with Antioxidant Potential. ACS omega 9 (16) (2024)
Digambar Kumar Waiker, Akash Verma, Poorvi Saraf, Gajendra T A, Sairam Krishnamurthy, Rameshwar Nath Chaurasia, Sushant Kumar Shrivastava
Development and Evaluation of Some Molecular Hybrids of N -(1-Benzylpiperidin-4-yl)-2-((5-phenyl-1,3,4-oxadiazol-2-yl)thio) as Multifunctional Agents to Combat Alzheimer's Disease. ACS omega 8 (10) (2023)
Digambar Kumar Waiker, Akash Verma, Poorvi Saraf, Gajendra T A, Sairam Krishnamurthy, Rameshwar Nath Chaurasia, Sushant Kumar Shrivastava
Development and Evaluation of Some Molecular Hybrids of N -(1-Benzylpiperidin-4-yl)-2-((5-phenyl-1,3,4-oxadiazol-2-yl)thio) as Multifunctional Agents to Combat Alzheimer's Disease. ACS omega 8 (10) (2023)
Digambar Kumar Waiker, Akash Verma, null Akhilesh, Gajendra T A, Namrata Singh, Anima Roy, Hagera Dilnashin, Vinod Tiwari, Surendra Kumar Trigun, Surya P Singh, Sairam Krishnamurthy, Prem Lama, Vincent Jo Davisson, Sushant Kumar Shrivastava
Design, Synthesis, and Biological Evaluation of Piperazine and N -Benzylpiperidine Hybrids of 5-Phenyl-1,3,4-oxadiazol-2-thiol as Potential Multitargeted Ligands for Alzheimer's Disease Therapy. ACS chemical neuroscience (2023)
Urmilesh Singh, null Laxmi, Prabhakar Singh, Ankit Kumar Singh, Sweksha Singh, Deepak Kumar, Sushant Kumar Shrivastava, Ravi Kumar Asthana
In silico and in vitro evaluation of extract derived from Dunaliella salina , a halotolerant microalga for its antifungal and antibacterial activity. Journal of biomolecular structure & dynamics (2022)
Piyoosh Sharma, Avanish Tripathi, Prabhash Nath Tripathi, Saumitra Sen Singh, Surya Pratap Singh, Sushant Kumar Shrivastava
Correction to "Novel Molecular Hybrids of N-Benzylpiperidine and 1,3,4-Oxadiazole as Multitargeted Therapeutics to Treat Alzheimer's Disease". ACS chemical neuroscience 11 (17) (2020)
Manish Kumar Tripathi, Piyoosh Sharma, Avanish Tripathi, Prabhash Nath Tripathi, Pavan Srivastava, Ankit Seth, Sushant Kumar Shrivastava
Computational exploration and experimental validation to identify a dual inhibitor of cholinesterase and amyloid-beta for the treatment of Alzheimer's disease. Journal of computer-aided molecular design 34 (9) (2020)
Piyoosh Sharma, Avanish Tripathi, Prabhash Nath Tripathi, Saumitra Sen Singh, Surya Pratap Singh, Sushant Kumar Shrivastava
Novel Molecular Hybrids of N-Benzylpiperidine and 1,3,4-Oxadiazole as Multitargeted Therapeutics to Treat Alzheimer's Disease. ACS chemical neuroscience 10 (10) (2019)

Sushant Kumar Shrivastava.css-eqlu8i{font-size:small;padding-left:4px;} (Sushant K Shrivastava)

Publication Activity (10 Years)

Top Topics

Top Venues

Sushant Kumar Shrivastava (Sushant K Shrivastava)